Side-by-side comparison of AI visibility scores, market position, and capabilities
SF YC W20 psychiatric EHR for ketamine/psychedelic/TMS treatment practices; $55.2M total ($40M DFJ/General Catalyst/Tiger Series B May 2022) competing with Valant for emerging mental health treatment specialty EHR.
Osmind is a San Francisco-based psychiatry and mental health EHR (electronic health record) platform — backed by Y Combinator (W20) with $55.2 million in total funding including a $40 million Series B in May 2022 led by DFJ Growth with General Catalyst, Future Ventures, Tiger Global, Susa Ventures, Lachy Groom, and Pear VC — providing psychiatric practices with research-grade EHR technology specialized for emerging mental health treatments including ketamine therapy, psychedelic-assisted psychotherapy (psilocybin, MDMA), transcranial magnetic stimulation (TMS), and electroconvulsive therapy (ECT). Founded in 2020, Osmind captures clinical data during novel psychiatric interventions in structured formats that enable both optimized patient care workflows and real-world evidence research — serving the growing segment of psychiatric practices offering treatment-resistant depression interventions.
Open-source browser-based API testing platform with 500K+ developers; $3M seed from OSS Capital competing with Postman as a lightweight, self-hostable alternative for REST and GraphQL testing.
Hoppscotch is an open-source API development and testing platform — providing a web-based, lightweight alternative to Postman and Insomnia for building, testing, and documenting REST, GraphQL, WebSocket, and gRPC APIs. Founded in 2019 by Liyas Thomas and Andrew Bastin in Kochi, India, Hoppscotch has grown to 500,000+ developers globally using the platform, raised $3 million in seed funding led by OSS Capital with participation from Automattic (WordPress.com parent), and offers a free open-source version alongside Hoppscotch Pro cloud with team collaboration and private workspaces.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.